Table 1 Disease-free failure estimates, follow up time and hazard ratios
All randomized patientsa | Original cohort of randomized patientsa | |||||||
|---|---|---|---|---|---|---|---|---|
Immediate/follicular phase | Scheduled/luteal phase | Immediate/follicular phase | Scheduled/luteal phase | |||||
Total randomized | 255 | 244 | 167 | 167 | ||||
Year | Total (Failures) | Failure probability (95% CI) | Total (Failures) | Failure probability (95% CI) | Total (Failures) | Failure probability (95% CI) | Total (Failures) | Failure probability (95% CI) |
1 | 246 (10) | 0.04 (0.02, 0.07) | 226 (18) | 0.07 (0.05, 0.11) | 163 (5) | 0.03 (0.01, 0.07) | 157 (11) | 0.07 (0.4, 0.12) |
3 | 210 (36) | 0.18 (0.14, 0.23) | 178 (45) | 0.26 (0.21, 0.32) | 137 (26) | 0.19 (0.13, 0.25) | 124 (31) | 0.25 (0.19, 0.33) |
5 | 118 (26) | 0.29 (0.24, 0.36) | 102 (20) | 0.36 (0.30, 0.43) | 116 (17) | 0.29 (0.23, 0.36) | 102 (18) | 0.36 (0.29, 0.44) |
Total eventsb | 78 | 85 | 54 | 62 | ||||
Average follow up time, years (SD) | 4.41(1.5) | 4.08 (1.8) | 4.77 (1.6) | 4.42 (1.9) | ||||
Event rateb | 69.4 | 85.4 | 67.8 | 83.9 | ||||
HRb (95% CI) | 1.24 (0.91, 1.68) | 1.25 (0.86, 1.79) | ||||||